PTCT
Companies
NASDAQ
Ptc Therapeutics Inc.
Health Care
$48.89
+$3.75 (+8.31%)
Price Chart
Overview
About PTCT
PTC Therapeutics Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when an RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology.
Market Cap
$2.8B
Volume
112.9M
Avg. Volume
73.8M
P/E Ratio
-12.502717
Dividend Yield
0.00%
Employees
1.2K
Company Information
Risk & Correlation Analysis
Market Correlation
1.21
Moderate Correlation
Volatility
High (0.56)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, PTCT shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$2.8B
Volume112.9M
P/E Ratio-12.50
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 7, 2025Related Securities
Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025